EdaƱo, Eufemia P.
HRN: 22-49-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
CEFTAZIDIME 1GM (VIAL)
02/02/2023
02/09/2023
IV
1g
OD
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes